Company Arch Biopartners Inc. Other OTC
Equities
ACHFF
CA03938C1041
Biotechnology & Medical Research
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Technologies
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +105.63% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +105.63% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Muruve
FOU | Founder | - | 03/03/83 |
Richard Muruve
FOU | Founder | - | 03/03/83 |
Andrew Bishop
DFI | Director of Finance/CFO | 58 | 31/03/10 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Rossman
BRD | Director/Board Member | - | 06/05/10 |
Richard Muruve
FOU | Founder | - | 03/03/83 |
Claude Allary
BRD | Director/Board Member | 69 | 31/03/14 |
Andrew Bishop
DFI | Director of Finance/CFO | 58 | 31/03/10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 62,855,633 | 50,559,037 ( 80.44 %) | 0 | 80.44 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+28.31% | 12.16B | |
+24.73% | 12.17B |